Swissana Clinic AG has been acquired by Hirslanden AG
The private shareholders of Swissana Clinic AG have sold the company to Hirslanden AG for an undisclosed consideration.
Swissana Clinic AG was founded in 1995 and is one of the leading independent hospitals in central Switzerland. It is equipped with three operating rooms, offers 20 in-patient beds with first class comfort and a day hospital with 11 beds.
Hirslanden is the leading group of private hospitals in Switzerland and operates 16 facilities throughout the country. It is owned by Medi-Clinic International, a listed company from South Africa.
Oaklins' team in Switzerland advised the sellers on the preparation of the divestment process and due diligence, the approach and negotiations with potential buyers, and assisted them until closing.
Talk to the deal team
Related deals
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more